Overview
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 101 days early.
- 202516/04/2026
- 202417/04/2025
- 202316/04/2024
- 202218/04/2023
- 202127/04/2022
- 202029/04/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Authorized Representatives
Manner of representation
1. The management board represents the company externally and manages the company's day-to-day operations. 2. The following are authorised to represent the company independently: A. the President of the Management Board and members of the management board; B. commercial proxies and attorneys-in-fact of the management board, within the scope of authority arising from resolutions of the management board. 3. The management board may dispose of a right or incur obligations to provide services with a value twenty times exceeding the amount of the company's share capital.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jan Krótkopadage 74 | 25 | $6,753.11 | 50% |
Zofia Agnieszka Krótkopadage 73 | 25 | $6,753.11 | 50% |
Jan Krótkopad and Zofia Agnieszka Krótkopad hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2001-12-27.
59 1500 1722 1217 2004 0803 0000
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $9,459.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $882$882 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Jun 16, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $6,923$6,923 | Polski Fundusz Rozwoju S.A. | |
| Jun 4, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Szczecin |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Ms-Pharmsp. z o.o. + limited partnership | $4,619,501.46 | mspharm.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl | ||
| Farmacja Im. O. Klimuszkisp. z o.o. | $1,289,548.20 | zyj-zdrowo.com | ||
| Twoja Tania Apteka Farmarsp. z o.o. | $440,843.57 | domlekow.pl | ||
| Nukloversp. z o.o. | $227,479.26 | nuklover.com | ||
| Massmedsp. z o.o. | $49,747.70 | mojoapps.co | ||
| Pharmer Polskasp. z o.o. | $15,884.06 | punktapteczny.online | ||
| DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A. | $2,740.83 | kwendasa.pl | ||
| Femaherbsp. z o.o. | $655.76 | femaherb.com | ||
| Przedsiębiorstwo Zaopatrzenia Farmaceutycznego Cefarm-SzczecinS.A. | – | farmacol.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2008-06-23 | Address change (Jodłowa 13, 71-296, Szczecin → Jodłowa 13 A, 71-114, Szczecin) | |
| 2001-12-13 | Entered in the register |
FAQ
Last updated: 2026-04-16